FDA Clearance Tracker · P080012
PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 7, 2012 (this decision)Source: openFDAMethods & limitations
Decided
Feb 7, 2012
Approved
Time to decision
1,397 days
Received Apr 11, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P080012
- Device name
- PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM
- Applicant
- Infusyn Therapeutics, LLC
- Applicant location
- Hackettstown, NJ
- Received
- Apr 11, 2008
- Decided
- Feb 7, 2012
- Decision
- Approved
- Supplements
- 63 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM. THE DEVICE IS INDICATED FOR INTRATHECAL INFUSION OF INFUMORPH (PRESERVATIVE-FREE MORPHINE SULFATE STERILE SOLUTION) OR PRESERVATIVE-FREE STERILE 0.9% SALINE SOLUTION (SODIUM CHLORIDE INJECTION, USP).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LKK. The earliest in FDA's data is P800036, decided Mar 3, 1982.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Infusyn Therapeutics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Prometra Programmable Infusion Pump SystemPMA supplement
P080012-S068 · Decided Jan 12, 2022 · 433 days after receipt · Panel Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.